[HTML][HTML] Maribavir for preemptive treatment of cytomegalovirus reactivation

J Maertens, C Cordonnier, P Jaksch… - … England Journal of …, 2019 - Mass Medical Soc
Background Maribavir is a benzimidazole riboside with activity against cytomegalovirus
(CMV). The safety and efficacy of maribavir for preemptive treatment of CMV infection in …

[HTML][HTML] Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation

J Maertens, C Cordonnier, P Jaksch… - … England Journal of …, 2019 - mpgjournal.mpg.es
Background Maribavir is a benzimidazole riboside with activity against cytomegalovirus
(CMV). The safety and efficacy of maribavir for preemptive treatment of CMV infection in …

Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation

J Maertens, C Cordonnier, P Jaksch… - The New England …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Maribavir is a benzimidazole riboside with activity against cytomegalovirus
(CMV). The safety and efficacy of maribavir for preemptive treatment of CMV infection in …

Maribavir for preemptive treatment of cytomegalovirus reactivation.

J Maertens, C Cordonnier, P Jaksch, X Poiré, M Uknis… - 2019 - cabidigitallibrary.org
Background Maribavir is a benzimidazole riboside with activity against cytomegalovirus
(CMV). The safety and efficacy of maribavir for preemptive treatment of CMV infection in …

Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation.

J Maertens, C Cordonnier, P Jaksch… - The New England …, 2019 - dial.uclouvain.be
BACKGROUND: Maribavir is a benzimidazole riboside with activity against cytomegalovirus
(CMV). The safety and efficacy of maribavir for preemptive treatment of CMV infection in …

Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation.

J Maertens, C Cordonnier, P Jaksch… - The New England …, 2019 - europepmc.org
Background Maribavir is a benzimidazole riboside with activity against cytomegalovirus
(CMV). The safety and efficacy of maribavir for preemptive treatment of CMV infection in …